Variable | Controls (n = 24) (%) | NO DR (n = 24) (%) | NPDR (n = 27) (%) | PDR (n = 24) (%) | F/χ2 value | p value |
---|---|---|---|---|---|---|
Age (years) | 60.23 ± 1.34 | 58.68 ± 1.54 | 58.28 ± 2.32 | 63.41 ± 1.99 | 1.64 | 0.183 |
Sex | ||||||
Female | 8 (36.4) | 9 (40.9) | 7 (28.0) | 5 (22.7) | 2.035 | 0.562 |
Male | 14 (63.6) | 13 (59.1) | 18 (72.0) | 17 (77.3) | Â | Â |
HbA1c (%) | 5.35 ± 0.11 | 7.91 ± 0.19 | 8.42 ± 0.28 | 8.88 ± 0.18 | 55.83 | < 0.001 |
BCVA | 0.09 ±  0.03 | 0.33 ± 0.14 | 0.74 ± 0.07 | 1.19 ± 0.02 | 105.74 | < 0.001 |
(log MAR) | (0.07–0.11) | (0.20–0.48) | (0.65–0.79) | (1.16–1.20) |  |  |
EZ | ||||||
Disruption absent | 22 (100.0) | 21 (95.5) | 14 (56.0) | 0 (0.0) | 60.59 | <Â 0.001 |
Disruption present | 0 (0.0) | 1 (4.5) | 11 (44.0) | 22 (100.0) | Â | Â |
RPE | ||||||
Disruption absent | 22 (100.0) | 22 (100.0) | 20 (80.0) | 0 (0.0) | 71.83 | <Â 0.001 |
Disruption present | 0 (0.0) | 0 (0.0) | 5 (20.0) | 22 (100.0) | Â | Â |
RI-OA | 0.61 ± 0.01 | 0.79 ± 0.01 | 0.81 ± 0.02 | 1.02 ± 0.09 | 14.23 | < 0.001 |